BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eusébio D, Neves AR, Costa D, Biswas S, Alves G, Cui Z, Sousa Â. Methods to improve the immunogenicity of plasmid DNA vaccines. Drug Discov Today 2021:S1359-6446(21)00280-4. [PMID: 34214667 DOI: 10.1016/j.drudis.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zareitaher T, Sadat Ahmadi T, Latif Mousavi Gargari S. Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting OmpW, TcpA and CtxB, ofVibrio cholerae. Immunobiology 2022. [DOI: 10.1016/j.imbio.2022.152190] [Reference Citation Analysis]
2 Zagorski K, Chailyan G, Hovakimyan A, Antonyan T, Kiani Shabestari S, Petrushina I, Davtyan H, Cribbs DH, Blurton-jones M, Masliah E, Agadjanyan MG, Ghochikyan A. Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein. IJMS 2022;23:6080. [DOI: 10.3390/ijms23116080] [Reference Citation Analysis]
3 Hayashi H, Sun J, Yanagida Y, Otera T, Kubota-koketsu R, Shioda T, Ono C, Matsuura Y, Arase H, Yoshida S, Nakamaru R, Ju N, Ide R, Tenma A, Kawabata S, Ehara T, Sakaguchi M, Tomioka H, Shimamura M, Okamoto S, Amaishi Y, Chono H, Mineno J, Komatsuno T, Saito Y, Rakugi H, Morishita R, Nakagami H. Preclinical study of a DNA vaccine targeting SARS-CoV-2. Current Research in Translational Medicine 2022. [DOI: 10.1016/j.retram.2022.103348] [Reference Citation Analysis]
4 Yang B, Guo ZR, Zhao Z, Wang T, Yang F, Ling F, Zhu B, Wang GX. Protective immunity by DNA vaccine against Micropterus salmoides rhabdovirus. J Fish Dis 2022. [PMID: 35930453 DOI: 10.1111/jfd.13672] [Reference Citation Analysis]
5 Shafaati M, Saidijam M, Soleimani M, Hazrati F, Mirzaei R, Amirheidari B, Tanzadehpanah H, Karampoor S, Kazemi S, Yavari B, Mahaki H, Safaei M, Rahbarizadeh F, Samadi P, Ahmadyousefi Y. A brief review on DNA vaccines in the era of COVID-19. Future Virol 2021. [PMID: 34858516 DOI: 10.2217/fvl-2021-0170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
6 Noh I, Lee K, Rhee YS. Microneedle systems for delivering nucleic acid drugs. J Pharm Investig 2022;:1-20. [PMID: 35003824 DOI: 10.1007/s40005-021-00558-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang Y, Chen‐mayfield T, Li Z, Younis MH, Cai W, Hu Q. Harnessing DNA for Immunotherapy: Cancer, Infectious Diseases, and Beyond. Adv Funct Materials. [DOI: 10.1002/adfm.202112273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rodolfo C, Eusébio D, Ventura C, Nunes R, Florindo HF, Costa D, Sousa Â. Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System. Pharmaceutics 2021;13:1369. [PMID: 34575445 DOI: 10.3390/pharmaceutics13091369] [Reference Citation Analysis]